{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:23:10Z","timestamp":1791894190173,"version":"4.3.4"},"reference-count":61,"publisher":"Keio Journal of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2302\/kjm.2023-0012-ir","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T22:57:31Z","timestamp":1695855451000},"page":"52-60","source":"Crossref","is-referenced-by-count":16,"title":["Pachyonychia Congenita: Clinical Features and Future          Treatments"],"prefix":"10.2302","volume":"74","author":[{"given":"Rebecca L.","family":"McCarthy","sequence":"first","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, The              Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust,              London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Brito","sequence":"additional","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, The              Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust,              London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, The              Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust,              London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Smith FJ, Jonkman MF, van Goor H, Coleman CM,          Covello SP, Uitto J, McLean WH: A mutation in human keratin K6b produces a phenocopy of          the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143\u20131148.          PMID:9618173 https:\/\/doi.org\/10.1093\/hmg\/7.7.1143","DOI":"10.1093\/hmg\/7.7.1143"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McLean WH, Rugg EL, Lunny DP, Morley SM, Lane EB,          Swensson O, Dopping-Hepenstal PJC, Griffiths WAD, Eady RAJ, Higgins C, Navsaria HA, Leigh          IM, Strachan T, Kunkeler L, Munro CS: Keratin 16 and keratin 17 mutations cause          pachyonychia congenita. Nat Genet 1995; 9: 273\u2013278.          https:\/\/doi.org\/10.1038\/ng0395-273","DOI":"10.1038\/ng0395-273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bowden PE, Haley JL, Kansky A, Rothnagel JA,          Jones DO, Turner RJ: Mutation of a type II keratin gene (K6a) in pachyonychia congenita.          Nat Genet 1995; 10: 363\u2013365. https:\/\/doi.org\/10.1038\/ng0795-363","DOI":"10.1038\/ng0795-363"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wilson NJ, Messenger AG, Leachman SA, O\u2019Toole EA,          Lane EB, Irwin McLean WH, Smith FJ: Keratin K6c mutations cause focal palmoplantar          keratoderma. J Invest Dermatol 2010; 130: 425\u2013429. PMID:19609311          https:\/\/doi.org\/10.1038\/jid.2009.215","DOI":"10.1038\/jid.2009.215"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Eliason MJ, Leachman SA, Feng B, Schwartz ME,          Hansen CD: A review of the clinical phenotype of 254 patients with genetically confirmed          pachyonychia congenita. J Am Acad Dermatol 2012; 67: 680\u2013686. PMID:22264670          https:\/\/doi.org\/10.1016\/j.jaad.2011.12.009","DOI":"10.1016\/j.jaad.2011.12.009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jacob JT, Coulombe PA, Kwan R, Omary MB: Types I          and II keratin intermediate filaments. Cold Spring Harb Perspect Biol 2018; 10: a018275.          https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5880164\/","DOI":"10.1101\/cshperspect.a018275"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhang X, Yin M, Zhang LJ: Keratin 6, 16 and          17\u2014critical barrier alarmin molecules in skin wounds and psoriasis. Cells 2019; 8: 807.          https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6721482\/","DOI":"10.3390\/cells8080807"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kaspar RL: Challenges in developing therapies for          rare diseases including pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10:          62\u201366. PMID:16250210 https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10208.x","DOI":"10.1111\/j.1087-0024.2005.10208.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Leachman SA, Kaspar RL, Fleckman P, Florell SR,          Smith FJ, McLean WH, Lunny DP, Milstone LM, van Steensel MA, Munro CS, O\u2019Toole EA, Celebi          JT, Kansky A, Lane EB: Clinical and pathological features of pachyonychia congenita. J          Investig Dermatol Symp Proc 2005; 10: 3\u201317. PMID:16250204          https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10202.x","DOI":"10.1111\/j.1087-0024.2005.10202.x"},{"key":"10","unstructured":"10. Jadassohn J, Lewandowsky F: Pachyonychia          congenita. Keratosis disseminata circumscripta (follicularis). Tylomata. Leukokeratosis          linguae. In: Jacob\u2019s Ikonographia Dermatologica, 1st ed. Berlin: Urban and Schwarzenberg,          1906; pp 29\u201330."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wilson NJ, Leachman SA, Hansen CD, McMullan AC,          Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ: A large mutational study in          pachyonychia congenita. J Invest Dermatol 2011; 131: 1018\u20131024. PMID:21326300          https:\/\/doi.org\/10.1038\/jid.2011.20","DOI":"10.1038\/jid.2011.20"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Samuelov L, Smith FJ, Hansen CD, Sprecher E:          Revisiting pachyonychia congenita: a case\u2010cohort study of 815 patients. Br J Dermatol          2020; 182: 738\u2013746. PMID:31823354 https:\/\/doi.org\/10.1111\/bjd.18794","DOI":"10.1111\/bjd.18794"},{"key":"13","unstructured":"13. Smith FJ, Hansen CD, Hull PR, Kaspar RL, McLean          WI, O\u2019Toole E, Sprecher E: Pachyonychia congenita. In: Adam MP, Mirzaa GM, Pagon RA,          editors. GeneReviews\u00ae 2017 Seattle (WA): University of Washington.          https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1280\/."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wilson NJ, O\u2019Toole EA, Milstone LM, Hansen CD,          Shepherd AA, Al-Asadi E, Schwartz ME, McLean WH, Sprecher E, Smith FJ: The molecular          genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol          2014; 171: 343\u2013355. PMID:24611874 https:\/\/doi.org\/10.1111\/bjd.12958","DOI":"10.1111\/bjd.12958"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zieman AG, Coulombe PA: Pathophysiology of          pachyonychia congenita\u2010associated palmoplantar keratoderma: new insights into skin          epithelial homeostasis and avenues for treatment. Br J Dermatol 2020; 182: 564\u2013573.          PMID:31021398 https:\/\/doi.org\/10.1111\/bjd.18033","DOI":"10.1111\/bjd.18033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen          CD, O\u2019Toole EA: Genotype\u2013phenotype correlations of neurovascular structures on the feet in          patients with pachyonychia congenita: a cross-sectional study. J Am Acad Dermatol 2022;          87: 1172\u20131174. PubMed https:\/\/doi.org\/10.1016\/j.jaad.2022.02.050","DOI":"10.1016\/j.jaad.2022.02.050"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Steele L, Schwartz J, Hansen CD, O\u2019Toole EA:          Prevalence and characterization of itch in pachyonychia congenita. JAMA Dermatol 2021;          157: 1378\u20131380. PubMed https:\/\/doi.org\/10.1001\/jamadermatol.2021.3335","DOI":"10.1001\/jamadermatol.2021.3335"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Goldberg I, Sprecher E, Schwartz ME, Gaitini D:          Comparative study of high-resolution multifrequency ultrasound of the plantar skin in          patients with various types of hereditary palmoplantar keratoderma. Dermatology 2013; 226:          365\u2013370. PMID:24030314 https:\/\/doi.org\/10.1159\/000351321","DOI":"10.1159\/000351321"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krupiczojc MA, O\u2019Toole EA: Plantar pain in          pachyonychia congenita. Br J Dermatol 2018; 179: 11\u201312. PMID:30156287          https:\/\/doi.org\/10.1111\/bjd.16700","DOI":"10.1111\/bjd.16700"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kerns ML, Hakim JM, Lu RG, Guo Y, Berroth A,          Kaspar RL, Coulombe PA: Oxidative stress and dysfunctional NRF2 underlie pachyonychia          congenita phenotypes. J Clin Invest 2016; 126: 2356\u20132366. PMID:27183391          https:\/\/doi.org\/10.1172\/JCI84870","DOI":"10.1172\/JCI84870"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wallis T, Poole CD, Hoggart B: Can skin disease          cause neuropathic pain? A study in pachyonychia congenita. Clin Exp Dermatol 2016; 41:          26\u201333. PubMed https:\/\/doi.org\/10.1111\/ced.12723","DOI":"10.1111\/ced.12723"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Treede RD, Jensen TS, Campbell JN, Cruccu G,          Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J: Neuropathic pain:          redefinition and a grading system for clinical and research purposes. Neurology 2008; 70:          1630\u20131635. PMID:18003941          https:\/\/doi.org\/10.1212\/01.wnl.0000282763.29778.59","DOI":"10.1212\/01.wnl.0000282763.29778.59"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Brill S, Sprecher E, Smith FJ, Geva N, Gruener H,          Nahman-Averbuch H, Defrin R: Chronic pain in pachyonychia congenita: evidence for          neuropathic origin. Br J Dermatol 2018; 179: 154\u2013162. PMID:29210461          https:\/\/doi.org\/10.1111\/bjd.16217","DOI":"10.1111\/bjd.16217"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Basset J, Marchal L, Hovnanian A: EGFR signaling          is overactive in pachyonychia congenita: effective treatment with oral erlotinib. J Invest          Dermatol 2023; 143: 294\u2013304. PMID:36116508          https:\/\/doi.org\/10.1016\/j.jid.2022.08.045","DOI":"10.1016\/j.jid.2022.08.045"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shah S, Boen M, Kenner-Bell B, Schwartz M,          Rademaker A, Paller AS: Pachyonychia congenita in pediatric patients: natural history,          features, and impact. JAMA Dermatol 2014; 150: 146\u2013153. PMID:24132595          https:\/\/doi.org\/10.1001\/jamadermatol.2013.6448","DOI":"10.1001\/jamadermatol.2013.6448"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Haber RM, Drummond D: Pachyonychia congenita with          laryngeal obstruction. Pediatr Dermatol 2011; 28: 429\u2013432. PMID:21554383          https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01232.x","DOI":"10.1111\/j.1525-1470.2011.01232.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cohn AM, McFarlane JR, Knox J: Pachyonychia          congenita with involvement of the larynx. Arch Otolaryngol 1976; 102: 233\u2013235. PubMed          https:\/\/doi.org\/10.1001\/archotol.1976.00780090075011","DOI":"10.1001\/archotol.1976.00780090075011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Benjamin B, Krisons DS, Molloy HF: Pachyonychia          congenita with laryngeal involvement. Int J Pediatr Otorhinolaryngol 1987; 13: 205\u2013209.          PMID:3667099 https:\/\/doi.org\/10.1016\/0165-5876(87)90097-8","DOI":"10.1016\/0165-5876(87)90097-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. O\u2019Kane AM, Jackson CP, Mahadevan M, Barber C:          Laryngeal manifestations of pachyonychia congenita: a clinical case and discussion on          management for the otolaryngologist. J Laryngol Otol 2017; 131: S53\u2013S56. PMID:27762179          https:\/\/doi.org\/10.1017\/S0022215116008264","DOI":"10.1017\/S0022215116008264"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Duverger O, Carlson JC, Karacz CM, Schwartz ME,          Cross MA, Marazita ML, Shaffer JR, Morasso MI: Genetic variants in pachyonychia          congenita-associated keratins increase susceptibility to tooth decay. PLoS Genet 2018; 14:          e1007168. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5794186\/.","DOI":"10.1371\/journal.pgen.1007168"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Goldberg I, Mashiah J, Kutz A, Derowe A,          Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD: Symptomatic mucosal involvement          in pachyonychia congenita: challenges in infants and young children. Br J Dermatol 2020;          182: 708\u2013713. PMID:31777952 https:\/\/doi.org\/10.1111\/bjd.18742","DOI":"10.1111\/bjd.18742"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Covello SP, Smith FJ, Sillevis Smitt JH, Paller          AS, Munro CS, Jonkman MF, Uitto J, McLean WH: Keratin 17 mutations cause either          steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139:          475\u2013480. PMID:9767294 https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02413.x","DOI":"10.1046\/j.1365-2133.1998.02413.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pavlovsky M, Peled A, Sarig O, Astman N, Malki L,          Meijers O, Assaf S, Schwartz J, Malovitski K, Hansen D, Sprecher E, Samuelov L:          Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a          coincidence. Br J Dermatol 2022; 187: 392\u2013400. PMID:35606927          https:\/\/doi.org\/10.1111\/bjd.21674","DOI":"10.1111\/bjd.21674"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kurokawa I, Takahashi K, Moll I, Moll R:          Expression of keratins in cutaneous epithelial tumors and related disorders\u2014distribution          and clinical significance. Exp Dermatol 2011; 20: 217\u2013228. PMID:21323743          https:\/\/doi.org\/10.1111\/j.1600-0625.2009.01006.x","DOI":"10.1111\/j.1600-0625.2009.01006.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hale GI, Wilson NJ, Smith FJ, Wylie G, Schwartz          ME, Zamiri M: Mutations in GJB6 causing phenotype resembling pachyonychia congenita. Br J          Dermatol 2015; 172: 1447\u20131449. PMID:25385569          https:\/\/doi.org\/10.1111\/bjd.13520","DOI":"10.1111\/bjd.13520"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lin Z, Chen Q, Lee M, Cao X, Zhang J, Ma D, Chen          L, Hu X, Wang H, Wang X, Zhang P, Liu X, Guan L, Tang Y, Yang H, Tu P, Bu D, Zhu X, Wang          K, Li R, Yang Y: Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted          syndrome. Am J Hum Genet 2012; 90: 558\u2013564. PMID:22405088          https:\/\/doi.org\/10.1016\/j.ajhg.2012.02.006","DOI":"10.1016\/j.ajhg.2012.02.006"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wilson NJ, Cole C, Milstone LM, Kiszewski AE,          Hansen CD, O\u2019Toole EA, Schwartz ME, Irwin McLean WH, Smith FJ: Expanding the phenotypic          spectrum of Olmsted syndrome. J Invest Dermatol 2015; 135: 2879\u20132883. PMID:26067147          https:\/\/doi.org\/10.1038\/jid.2015.217","DOI":"10.1038\/jid.2015.217"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Pohler E, Mamai O, Hirst J, Zamiri M, Horn H,          Nomura T, Irvine AD, Moran B, Wilson NJ, Smith FJD, Goh CSM, Sandilands A, Cole C, Barton          GJ, Evans AT, Shimizu H, Akiyama M, Suehiro M, Konohana I, Shboul M, Teissier S,          Boussofara L, Denguezli M, Saad A, Gribaa M, Dopping-Hepenstal PJ, McGrath JA, Brown SJ,          Goudie DR, Reversade B, Munro CS, Irwin McLean WH: Haploinsufficiency for AAGAB causes          clinically heterogeneous forms of punctate palmoplantar keratoderma. Nat Genet 2012;          44:1272\u20131276. https:\/\/doi.org\/10.1038\/ng.2444","DOI":"10.1038\/ng.2444"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lovgren ML, McAleer MA, Irvine AD, Wilson NJ,          Tavadia S, Schwartz ME, Cole C, Sandilands A, Smith FJD, Zamiri M: Mutations in desmoglein          1 cause diverse inherited palmoplantar keratoderma phenotypes: implications for genetic          screening. Br J Dermatol 2017; 176: 1345\u20131350.          https:\/\/doi.org\/10.1111\/bjd.14973","DOI":"10.1111\/bjd.14973"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Has C, Technau-Hafsi K: Palmoplantar          keratodermas: clinical and genetic aspects. J Dtsch Dermatol Ges 2016; 14: 123\u2013139.          PMID:26819106 PMID:26819106https:\/\/doi.org\/10.1111\/ddg.12930","DOI":"10.1111\/ddg.12930"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Has C, Bauer JW, Bodemer C, Bolling MC,          Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich MP, Martinez          AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K,          Uitto J, Woodley DT, Zambruno G, Mellerio JE: Consensus reclassification of inherited          epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183:          614\u2013627. PMID:32017015 https:\/\/doi.org\/10.1111\/bjd.18921","DOI":"10.1111\/bjd.18921"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Sharma RK, Gupta M, Sood S, Gupta A: Dyskeratosis          congenita: presentation of cutaneous triad in a sporadic case. BMJ Case Reports CP 2018;          11: e226736. http:\/\/dx.doi.org\/10.1136\/bcr-2018-226736","DOI":"10.1136\/bcr-2018-226736"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Collins SM, Dominguez M, Ilmarinen T, Costigan C,          Irvine AD: Dermatological manifestations of autoimmune          polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 2006; 154:          1088\u20131093. PubMed https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07166.x","DOI":"10.1111\/j.1365-2133.2006.07166.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kasparis C, Reid D, Wilson NJ, Okur V, Cole C,          Hansen CD, Bosse K, Betz RC, Khan M, Smith FJD: Isolated recessive nail dysplasia caused          by FZD6 mutations: report of three families and review of the literature. Clin Exp          Dermatol 2016; 41: 884\u2013889. https:\/\/doi.org\/10.1111\/ced.12934","DOI":"10.1111\/ced.12934"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Milstone LM, Fleckman P, Leachman SA, Leigh IM,          Paller AS, van Steensel MA, Swartling C: Treatment of pachyonychia congenita. J Investig          Dermatol Symp Proc 2005; 10: 18\u201320. PMID:16250205          https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10203.x","DOI":"10.1111\/j.1087-0024.2005.10203.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Goldberg I, Fruchter D, Meilick A, Schwartz M,          Sprecher E: Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol          Venereol 2014; 28: 279\u2013285. PubMed https:\/\/doi.org\/10.1111\/jdv.12098","DOI":"10.1111\/jdv.12098"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Basset J, Marchal L, Hovnanian A: EGFR signaling          is overactive in pachyonychia congenita: effective treatment with oral erlotinib. J Invest          Dermatol 2023; 143: 294\u2013304. PMID:36116508          https:\/\/doi.org\/10.1016\/j.jid.2022.09.275","DOI":"10.1016\/j.jid.2022.08.045"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Gruber R, Edlinger M, Kaspar RL, Hansen CD,          Leachman S, Milstone LM, Smith FJ, Sidoroff A, Fritsch PO, Schmuth M: An appraisal of oral          retinoids in the treatment of pachyonychia congenita. J Am Acad Dermatol 2012; 66:          e193\u2013e199. PubMed https:\/\/doi.org\/10.1016\/j.jaad.2011.02.003","DOI":"10.1016\/j.jaad.2011.02.003"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. DeKlotz CM, Schwartz ME, Milstone LM: Nail          removal in pachyonychia congenita: patient-reported survey outcomes. J Am Acad Dermatol          2017; 76: 990\u2013992. PMID:28411774          https:\/\/doi.org\/10.1016\/j.jaad.2016.08.060","DOI":"10.1016\/j.jaad.2016.08.060"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Hickerson RP, Leake D, Pho LN, Leachman SA,          Kaspar RL: Rapamycin selectively inhibits expression of an inducible keratin (K6a) in          human keratinocytes and improves symptoms in pachyonychia congenita patients. J Dermatol          Sci 2009; 56: 82\u201388. PMID:19699613          https:\/\/doi.org\/10.1016\/j.jdermsci.2009.07.008","DOI":"10.1016\/j.jdermsci.2009.07.008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Teng JM, Bartholomew FB, Patel V, Sun G: Novel          treatment of painful plantar keratoderma in pachyonychia congenita using topical          sirolimus. Clin Exp Dermatol 2018; 43: 968\u2013971. PMID:29882237          https:\/\/doi.org\/10.1111\/ced.13686","DOI":"10.1111\/ced.13686"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Theocharopoulos I, O\u2019Toole EA: Stopping          pachyonychia congenita plantar pain with a statin? Br J Dermatol 2019; 181: 446\u2013447.          https:\/\/doi.org\/10.1111\/bjd.18254","DOI":"10.1111\/bjd.18254"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Zhao Y, Gartner U, Smith FJ, McLean WH: Statins          downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia          congenita. J Invest Dermatol 2011; 131: 1045\u20131052. PMID:21390048          https:\/\/doi.org\/10.1038\/jid.2011.41","DOI":"10.1038\/jid.2011.41"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Ruscica M, Ferri N, Banach M, Sirtori CR, Corsini          A: Side effects of statins: from pathophysiology and epidemiology to diagnostic and          therapeutic implications. Cardiovasc Res 2023; 118: 3288\u20133304. PMID:35238338          https:\/\/doi.org\/10.1093\/cvr\/cvac020","DOI":"10.1093\/cvr\/cvac020"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Koren A, Sprecher E, Reider E, Artzi O: A          treatment protocol for botulinum toxin injections in the treatment of pachyonychia          congenita\u2010associated keratoderma. Br J Dermatol 2020; 182: 671\u2013677. PMID:31127950          https:\/\/doi.org\/10.1111\/bjd.18169","DOI":"10.1111\/bjd.18169"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Swartling C, Vahlquist A: Treatment of          pachyonychia congenita with plantar injections of botulinum toxin. Br J Dermatol 2006;          154: 763\u2013765. PMID:16536826          https:\/\/doi.org\/10.1111\/j.1365-2133.2005.07115.x","DOI":"10.1111\/j.1365-2133.2005.07115.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Thomas BR, Sahota A: Pachyonychia congenita and          botulinum toxin. Br J Dermatol 2020; 182: 531\u2013532. PMID:31875943          https:\/\/doi.org\/10.1111\/bjd.18784","DOI":"10.1111\/bjd.18784"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Leachman SA, Hickerson RP, Hull PR, Smith FJ,          Milstone LM, Lane EB, Bale SJ, Roop DR, McLean WH, Kaspar RL: Therapeutic siRNAs for          dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 2008; 51:          151\u2013157. PMID:18495438 https:\/\/doi.org\/10.1016\/j.jdermsci.2008.04.003","DOI":"10.1016\/j.jdermsci.2008.04.003"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Hickerson RP, Flores MA, Leake D, Lara MF, Contag          CH, Leachman SA, Kaspar RL: Use of self-delivery siRNAs to inhibit gene expression in an          organotypic pachyonychia congenita model. J Invest Dermatol 2011; 131: 1037\u20131044.          PMID:21248764 https:\/\/doi.org\/10.1038\/jid.2010.426","DOI":"10.1038\/jid.2010.426"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Greco C, Ponsen AC, Leclerc-Mercier S, Schlatter          J, Cisternino S, Boucheix C, Bodemer C: Treatment of painful palmoplantar keratoderma          related to pachyonychia congenita using EGFR inhibitors. Biomedicines 2022; 10: 841.          https:\/\/doi.org\/10.3390\/biomedicines10040841","DOI":"10.3390\/biomedicines10040841"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Vignes S, Baran R: Yellow nail syndrome: a          review. Orphanet J Rare Dis 2017; 12: 42. PMID:28241848          https:\/\/doi.org\/10.1186\/s13023-017-0594-4","DOI":"10.1186\/s13023-017-0594-4"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0012-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:07:06Z","timestamp":1743221226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0012-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2023-0012-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2023-0012-IR"}}